Premium
p21 Waf1/cip1 acts in synergy with bcl‐2 to confer multidrug resistance in a camptothecin‐selected human lung‐cancer cell line
Author(s) -
Zhang Yongke,
Fujita Naoya,
Tsuruo Takashi
Publication year - 1999
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19991210)83:6<790::aid-ijc15>3.0.co;2-6
Subject(s) - camptothecin , apoptosis , a549 cell , cell culture , biology , cancer research , multiple drug resistance , cancer cell , transfection , caspase , drug resistance , cancer , programmed cell death , biochemistry , microbiology and biotechnology , genetics
The realization that chemotherapeutic agents induce apoptosis raises the concern that tumors resistant to chemotherapy are unable to initiate the apoptotic program. In the present study, we examined the apoptosis‐resistance mechanism of a multidrug‐resistant cell line, A549/CPT, which was established from the human lung‐cancer cell line A549 by in vitro selection with gradually increased camptothecin (CPT) concentrations. We found that A549/CPT cells were resistant to anti‐cancer drug‐induced apoptosis in which caspase‐3‐like protease activity was attenuated remarkably, compared with parental A549 cells. We observed 2 mechanisms associated with apoptosis resistance in A549/CPT cells: over‐expression of anti‐apoptotic bcl‐2 and elevated expression of p21 Waf1/Cip1 . Transfection of either bcl‐2 or p21 Waf1/Cip1 cDNA into parental A549 cells resulted in resistance to apoptosis. Furthermore, the co‐treatment of p21 Waf1/Cip1 and bcl‐2 anti‐sense oligodeoxynucleotides restored drug susceptibility in A549/CPT cells more effectively than either one of them alone. These results indicate that co‐induction of bcl‐2 and p21 Waf1/Cip1 in A549/CPT cells may be involved in acquired drug resistance by inhibiting caspase‐mediated apoptosis. Agents aimed at preventing both bcl‐2 and p21 Waf1/Cip1 expression may increase the efficiency of chemotherapy. Int. J. Cancer 83:790–797, 1999. © 1999 Wiley‐Liss, Inc.